Imunon, Inc. (IMNN)
3.395
-0.06
(-1.88%)
USD |
NASDAQ |
Mar 05, 16:00
3.395
0.00 (0.00%)
After-Hours: 19:00
Imunon Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| Corcept Therapeutics, Inc. | -11.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.441M |
| Cash from Financing (Quarterly) | 4.963M |
| Free Cash Flow | -14.95M |
| Free Cash Flow Per Share (Quarterly) | -1.509 |
| Free Cash Flow to Equity (Quarterly) | -4.350M |
| Free Cash Flow to Firm (Quarterly) | -4.441M |
| Free Cash Flow Yield | -52.63% |